This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
05/05/15 - 3:13:51 PM ET (BATS BZX Real-time Price)
Div Yield: --
ATRS Day's Range
ATRS 52 Week Range
ATRS Business Summary
Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide.View ATRS key stats
Antares Pharma Inc - ATRS - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Antares Pharma Inc as a
Sell with a ratings score of D.
Report Snippet: We rate ANTARES PHARMA INC (ATRS) a SELL. This is driven by some concerns, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share.